Beranda › Hidradenitis Suppurativa › Michigan
Uji klinis Hidradenitis Suppurativa di Michigan
6 studi untuk Hidradenitis Suppurativa mencari peserta di lokasi di Michigan.
Kota di Michigan
Teks studi resmi (Bahasa Inggris)
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Canton
Menerima pesertaFase 2
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07783542Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US061, Ann Arbor
- Investigative Site US120, Detroit
- Investigative Site US091, Troy
- dan 1 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06855498Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Oakland Hills Dermatology Pc, Auburn Hills
- Wayne State University Physician Group Dermatology, Detroit
- Revival Research Institute, Llc Troy, Troy
Menerima pesertaFase 2
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07213973A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
- Wayne State University, Detroit
- Hamzavi Dermatology, Fort Gratiot
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mar 2026 · NCT07244263A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
- University of Michigan Health System - Ann Arbor /ID# 267275, Ann Arbor
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 24 Jan 2025 · NCT06524635Battlefield Acupuncture for Pain in Hidradenitis Suppurativa
- WSUPG Dermatology, Dearborn
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Mei 2023 · NCT04218422Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.